Download presentation
Presentation is loading. Please wait.
Published byAshley Nash Modified over 6 years ago
1
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida, MD, PhD, Taiki Fujiwara, MD, PhD, Hironobu Wada, MD, PhD, Takahiro Nakajima, MD, PhD, Hidemi Suzuki, MD, PhD, Ichiro Yoshino, MD, PhD The Annals of Thoracic Surgery Volume 102, Issue 6, Pages (December 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 (A) Kaplan-Meier progression-free survival for idiopathic pulmonary fibrosis (IPF), comparing the perioperative pirfenidone treatment (PPT) group with the non-PPT group. The first acute exacerbation (AE) after operation was treated as a progression event. (B) Cumulative incidence curves depicting first AE-IPF after operation for PPT and non-PPT patients. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.